Published in J Neurol Sci on June 15, 2001
Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain (2010) 2.61
Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology (2010) 1.56
Association between comorbidity and clinical characteristics of MS. Acta Neurol Scand (2010) 0.90
Ipsilateral uveitis and optic neuritis in multiple sclerosis. Mult Scler Int (2012) 0.82
The retrovirus/superantigen hypothesis of multiple sclerosis. Cell Mol Neurobiol (2014) 0.77
Uveitis associated with multiple sclerosis: complications and visual prognosis. Int J Ophthalmol (2014) 0.75
Intermediate uveitis: pattern of etiology, complications, treatment and outcome in a tertiary academic center. Orphanet J Rare Dis (2017) 0.75
Second consensus statement on the diagnosis of multiple system atrophy. Neurology (2008) 7.27
Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology (2006) 6.44
Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci (1999) 5.01
Vitamin A supplementation and increased prevalence of childhood diarrhoea and acute respiratory infections. Lancet (1993) 4.35
Primary structure of human T-cell receptor alpha-chain. Nature (1985) 2.93
The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol (1998) 2.72
The "three delays" as a framework for examining maternal mortality in Haiti. Soc Sci Med (1998) 2.29
Molecular genetic alterations in glioblastomas with oligodendroglial component. Acta Neuropathol (2001) 2.17
Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet (1995) 2.13
The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study. Neurology (2011) 2.06
Prevalence of antigliadin antibodies in ataxia patients. Neurology (2003) 1.89
Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clin Auton Res (1998) 1.71
Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis. Arch Neurol (2001) 1.67
Self heat shock and gamma delta T-cell reactivity. Proc Natl Acad Sci U S A (1990) 1.63
Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease. Trends Neurosci (1989) 1.57
Potassium deprivation-induced apoptosis of cerebellar granule neurons: a sequential requirement for new mRNA and protein synthesis, ICE-like protease activity, and reactive oxygen species. J Neurosci (1996) 1.56
Magnetic resonance imaging in hereditary and idiopathic ataxia. Neurology (1993) 1.55
Overexpression of tumor necrosis factor-alpha produces an increase in lung volumes and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2001) 1.53
Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology (2008) 1.53
Cell death and apoptosis regulating proteins in Parkinson's disease--a cautionary note. Acta Neuropathol (1999) 1.48
Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Ann Neurol (1999) 1.44
Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT. J Neurol Neurosurg Psychiatry (1994) 1.41
Spinocerebellar ataxia type 6: evidence for a strong founder effect among German families. Neurology (1999) 1.39
MRI findings in Hirayama's disease: flexion-induced cervical myelopathy or intrinsic motor neuron disease? J Neurol (1999) 1.36
The aetiology of sporadic adult-onset ataxia. Brain (2002) 1.34
Patterns of age-related shrinkage in cerebellum and brainstem observed in vivo using three-dimensional MRI volumetry. Cereb Cortex (1999) 1.34
Control of MRSA in a long-term care facility. Infect Control Hosp Epidemiol (1994) 1.30
Consensus statement on the diagnosis of multiple system atrophy. J Auton Nerv Syst (1998) 1.25
Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo. J Neurosci (2000) 1.25
Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families. Hum Mol Genet (1997) 1.24
Expression of new idiotypes following neonatal idiotypic suppression of a dominant clone. Eur J Immunol (1976) 1.23
Autosomal dominant cerebellar ataxia type I: oculomotor abnormalities in families with SCA1, SCA2, and SCA3. J Neurol (1999) 1.21
An isoform of ataxin-3 accumulates in the nucleus of neuronal cells in affected brain regions of SCA3 patients. Brain Pathol (1998) 1.17
Dominantly inherited expression of BID, an invariant undiversified T cell receptor delta chain. Cell (1990) 1.16
Responsiveness of different rating instruments in spinocerebellar ataxia patients. Neurology (2010) 1.15
Use of ethnographic research for instrument development in a case-control study of immunization use in Haiti. Int J Epidemiol (1989) 1.15
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2. J Neurosci (1998) 1.14
Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease. J Neuropathol Exp Neurol (2001) 1.10
Glutathione depletion and neuronal cell death: the role of reactive oxygen intermediates and mitochondrial function. Brain Res (1999) 1.08
Autosomal dominant cerebellar ataxia type I clinical features and MRI in families with SCA1, SCA2 and SCA3. Brain (1996) 1.07
Does high-field MR imaging have an influence on the classification of patients with clinically isolated syndromes according to current diagnostic mr imaging criteria for multiple sclerosis? AJNR Am J Neuroradiol (2006) 1.06
The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases. Mol Cell Biochem (1997) 1.06
Identification of inhibitor-of-differentiation 2 (Id2) as a modulator of neuronal apoptosis. J Neurochem (2002) 1.06
The European Multiple System Atrophy-Study Group (EMSA-SG). J Neural Transm (Vienna) (2005) 1.05
Probable multiple system atrophy in a German family. J Neurol Neurosurg Psychiatry (2004) 1.05
Voxel-based morphometry and voxel-based relaxometry in multiple system atrophy-a comparison between clinical subtypes and correlations with clinical parameters. Neuroimage (2007) 1.04
Cognitive deficits in spinocerebellar ataxia type 1, 2, and 3. J Neurol (2003) 1.04
Molecular analysis of the PTEN, TP53 and CDKN2A tumor suppressor genes in long-term survivors of glioblastoma multiforme. J Neurooncol (2000) 1.04
SCA6 is caused by moderate CAG expansion in the alpha1A-voltage-dependent calcium channel gene. Hum Mol Genet (1997) 1.04
Prospective analysis of falls in dominant ataxias. Eur Neurol (2012) 1.00
Mechanism of cyclization of pyridine nucleotides by bovine spleen NAD+ glycohydrolase. J Biol Chem (1996) 1.00
Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase. J Neuroimmunol (1999) 1.00
SCA Functional Index: a useful compound performance measure for spinocerebellar ataxia. Neurology (2008) 1.00
Neuropsychological outcome after chemotherapy for primary CNS lymphoma: a prospective study. Neurology (2005) 0.99
Cooperative interception of neuronal apoptosis by BCL-2 and BAG-1 expression: prevention of caspase activation and reduced production of reactive oxygen species. J Neurochem (1997) 0.98
In vitro secondary MLR. III: Hybrid histocompatibility determinants. J Immunol (1978) 0.98
Cognitive deficits in spinocerebellar ataxia 2. Brain (1999) 0.98
Sporadic adult onset ataxia of unknown etiology : a clinical, electrophysiological and imaging study. J Neurol (2007) 0.98
EFNS/ENS Consensus on the diagnosis and management of chronic ataxias in adulthood. Eur J Neurol (2014) 0.97
High level expression of expanded full-length ataxin-3 in vitro causes cell death and formation of intranuclear inclusions in neuronal cells. Hum Mol Genet (1999) 0.97
Sporadic cerebellar ataxia associated with gluten sensitivity. Brain (2001) 0.97
Extended therapeutic window for caspase inhibition and synergy with MK-801 in the treatment of cerebral histotoxic hypoxia. Cell Death Differ (1998) 0.97
Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-alpha/lipopolysaccharide. J Neurochem (1998) 0.97
Commitment and maintenance of the alpha beta and gamma delta T cell lineages. J Immunol (1995) 0.96
Autosomal dominant familial spastic paraplegia: reduction of the FSP1 candidate region on chromosome 14q to 7 cM and locus heterogeneity. Am J Hum Genet (1995) 0.96
Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones. Neuroreport (1996) 0.96
Treatment of steroid-unresponsive tumefactive demyelinating disease with plasma exchange. Neurology (2003) 0.95
Differential effects of the excitatory amino acid antagonists, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and 3-((+-)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP), on spinal reflex activity in mice. Neurosci Lett (1990) 0.94
Adenovirus-mediated gene transfer of inhibitors of apoptosis protein delays apoptosis in cerebellar granule neurons. J Neurochem (1999) 0.93
Autosomal dominant cerebellar ataxia type I. Nerve conduction and evoked potential studies in families with SCA1, SCA2 and SCA3. Brain (1997) 0.93
Induction and characterization of "autologous" anti-isiotypic antibodies. Eur J Immunol (1977) 0.93
Muscle relaxant action of excitatory amino acid antagonists. Neurosci Lett (1985) 0.92
Cell death in polyglutamine diseases. Cell Tissue Res (2000) 0.92
Homing and in situ differentiation of resident pulmonary lymphocytes. Int Immunol (1994) 0.92
Social and psychological costs of preventive child health services in Haiti. Soc Sci Med (1994) 0.92
Phenotype assignment in symptomatic female carriers of X-linked adrenoleukodystrophy. J Neurol (2001) 0.92
Differential effects of L-buthionine sulfoximine and ethacrynic acid on glutathione levels and mitochondrial function in PC12 cells. Neurosci Lett (1999) 0.92
Mechanical thrombectomy compared to local-intraarterial thrombolysis in carotid T and middle cerebral artery occlusions: a single center experience. Clin Neuroradiol (2011) 0.91
New insights into the metabolic consequences of large-scale mtDNA deletions: a quantitative analysis of biochemical, morphological, and genetic findings in human skeletal muscle. J Neuropathol Exp Neurol (2000) 0.91
Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind 31P-MRS crossover study. Eur J Neurol (2005) 0.91
Fixation instability and oculomotor abnormalities in Friedreich's ataxia. J Neurol (1995) 0.90
Restless legs syndrome in spinocerebellar ataxia types 1, 2, and 3. J Neurol (2001) 0.90
Cricopharyngeal achalasia is a common cause of dysphagia in patients with mtDNA deletions. Neurology (2001) 0.89
Dominant expression of the T cell receptor BALB invariant delta (BID) chain in resident pulmonary lymphocytes is due to selection. Eur J Immunol (1991) 0.89
L-carnitine and creatine in Friedreich's ataxia. A randomized, placebo-controlled crossover trial. J Neural Transm (Vienna) (2004) 0.89
Role of IL-7 in the shaping of the pulmonary gamma delta T cell repertoire. J Immunol (1996) 0.89
Apoptotic cell death in the cerebellum of mutant weaver and lurcher mice. Neurosci Lett (1995) 0.88
Inflammatory genes are upregulated in expanded ataxin-3-expressing cell lines and spinocerebellar ataxia type 3 brains. J Neurosci (2001) 0.88
The methionine synthase polymorphism D919G alters susceptibility to primary central nervous system lymphoma. Br J Cancer (2004) 0.88
Local intra-arterial thrombolysis in the carotid territory: does recanalization depend on the thromboembolus type? Neuroradiology (2002) 0.88
Acetazolamide-responsive migraine in CADASIL. Neurology (1998) 0.88
Ataxia and tremor due to lesions involving cerebellar projection pathways: a DTI tractographic study in six patients. J Neurol (2014) 0.88
MPP+ inhibits proliferation of PC12 cells by a p21(WAF1/Cip1)-dependent pathway and induces cell death in cells lacking p21(WAF1/Cip1). Exp Cell Res (1999) 0.87
Screening for proteins with polyglutamine expansions in autosomal dominant cerebellar ataxias. Hum Mol Genet (1996) 0.87
Chromosomal mapping in the mouse of eight K(+)-channel genes representing the four Shaker-like subfamilies Shaker, Shab, Shaw, and Shal. Genomics (1993) 0.87
Cholinergic chemosensory cells in the auditory tube. Histochem Cell Biol (2012) 0.87
MTX-induced white matter changes are associated with polymorphisms of methionine metabolism. Neurology (2005) 0.87
Executive dysfunction in spinocerebellar ataxia type 1. Eur Neurol (2001) 0.87
Meningioma of the optic nerve sheath: treatment with hydroxyurea. J Neurol Neurosurg Psychiatry (2003) 0.87
A new semiautomated, three-dimensional technique allowing precise quantification of total and regional cerebellar volume using MRI. Magn Reson Med (1998) 0.87